Skip to main content
GPT Healthcare Limited logo

GPT Healthcare Limited — Investor Relations & Filings

Ticker · GPTHEALTH ISIN · INE486R01017 LEI · 335800QKUFW7XBRKWD85 BSE.NS Human health and social work activities
Filings indexed 204 across all filing types
Latest filing 2026-06-05 Regulatory Filings
Country IN India
Listing BSE.NS GPTHEALTH

About GPT Healthcare Limited

https://www.gptgroup.co.in

GPT Healthcare Limited operates a network of multi-specialty hospitals under the ILS Hospitals brand. The organization provides comprehensive tertiary care services across diverse medical fields, including internal medicine, nephrology, laparoscopic surgery, orthopaedics, and gynaecology. Its service portfolio extends to maternity, paediatrics, and advanced diagnostic procedures. The company utilizes a mid-sized hospital model to deliver specialized medical treatments, supported by modern infrastructure such as intensive care units and advanced surgical theaters. GPT Healthcare focuses on clinical excellence and patient-centric delivery, maintaining a range of diagnostic and therapeutic facilities to address complex medical conditions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 78% confidence The document is a notice filed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the schedule of analyst/institutional investor meetings. It does not contain financial statements or serve as the actual investor presentation; it only informs about the meeting schedule and compliance with listing regulations. This is a general regulatory announcement rather than an AGM material, earnings release, or detailed report. Therefore, it falls under Regulatory Filings (RNS).
2026-06-05 English
Please find enclosed herewith the Letter for Investor Meet on June 11, 2026.
Regulatory Filings Classification · 87% confidence The document is an intimation under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 concerning the schedule of analyst/institutional investor meetings. It does not contain financial statements, earnings data, or presentation content itself, nor is it a presentation; instead it is a statutory/regulatory compliance notice to stock exchanges. This fits the Regulatory Filings fallback category (RNS).
2026-06-05 English
Please find enclosed herewith the Annual Secretarial Compliance Report for year ended March 31, 2026.
Regulatory Filings Classification · 82% confidence The document is an Annual Secretarial Compliance Report issued by a Practicing Company Secretary pursuant to SEBI Listing Regulations. It is a statutory compliance certificate/attestation rather than the company’s own annual or interim financial report. It is neither an earnings release nor a management discussion, nor a board change. It falls under general regulatory filings and certifications. Therefore, it should be classified as Regulatory Filings (RNS).
2026-05-26 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a short stock exchange filing under SEBI Listing Regulations (Regulation 30) notifying the publication of a newspaper advertisement (“Second 100-Days Campaign – Saksham Niveshak”). It does not contain substantive financial statements or management discussion; it is a routine regulatory disclosure. This falls under the general regulatory announcements category (RNS).
2026-05-23 English
Please find enclosed herewith the Copies of News Paper Publication in connection with Second 100 Days Campaign-"Saksham Niveshak"
Regulatory Filings Classification · 85% confidence The document is formatted as an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, addressed to the BSE and NSE, notifying the stock exchanges of a newspaper advertisement campaign (“Second 100-Days Campaign”). There are no financial statements or substantive financial data, nor details of dividend, share issuance, AGM materials, or earnings. It is a compliance/regulatory disclosure under listing rules, which falls under the “Regulatory Filings” (RNS) category.
2026-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 98% confidence The document is a formal submission to stock exchanges enclosing the full text of a conference call on the company’s audited financial results for Q4 and FY ’26. It includes the moderator’s introduction, management’s opening remarks, financial metrics, and Q&A. This matches the definition of a Call Transcript (CT).
2026-05-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.